Peptide Education

Peptide Therapy: Research & Education

Pending FDA 503A Pathway

Educational content on therapeutic peptides, preclinical research, and the evolving FDA regulatory framework. This content is for informational purposes only and does not constitute medical advice or an offer to sell.

Join the Peptide Waitlist
Foundations
Pending FDA 503A Pathway

Peptide Science & Regulation

Peptide Foundations

What Is Peptide Therapy?

8 min read

An introduction to therapeutic peptides: the science behind them, current research directions, and the regulatory landscape.

Join Waitlist →
Regulatory

Peptide Compounding & the FDA 503A Pathway

7 min read

Understanding the evolving regulatory framework for compounded peptides and what it means for patient access.

Join Waitlist →
Safety

Peptide Safety & Quality Considerations

6 min read

What patients should understand about peptide sourcing, purity testing, and the importance of physician oversight.

Join Waitlist →
Tranche 1
Pending FDA 503A Pathway

Recovery & Repair Research

Recovery Research

BPC-157: Current Research Overview

10 min read

What the preclinical literature shows about BPC-157, its proposed mechanisms of action, and what remains unknown.

Join Waitlist →
Recovery Research

TB-500 (Thymosin Beta-4): Research Overview

9 min read

A review of preclinical research on TB-500, its proposed role in tissue repair, and current limitations of the evidence.

Join Waitlist →
Longevity
Pending FDA 503A Pathway

Longevity & Cellular Energy

Longevity

NAD+ & Longevity: What the Research Shows

8 min read

An overview of NAD+ supplementation research, cellular energy metabolism, and the emerging longevity science.

Available Now via Longevity StackBook Consultation →
Tranche 2-3
Pending FDA 503A Pathway

Advanced Protocols

Advanced Protocols

Growth Hormone Peptides: A Research Overview

11 min read

What the research shows about growth hormone secretagogues, including CJC-1295, ipamorelin, and related compounds.

Join Waitlist →
Outlook
Pending FDA 503A Pathway

Regulatory & Clinical Landscape

Regulatory Outlook

The Future of Peptide Therapy: Regulatory & Clinical Landscape

7 min read

Where peptide therapy is headed: FDA pathway updates, clinical trial activity, and what patients should watch for.

Join Waitlist →

Peptide Roadmap

Pending FDA 503A Pathway
Tranche 1

Recovery & Repair Peptides

BPC-157, TB-500, pending FDA 503A pathway clearance. Waitlist open for patient interest.

Tranche 2

Growth Hormone Secretagogues

CJC-1295, Ipamorelin, dependent on regulatory pathway and clinical evidence review.

Tranche 3

Advanced Research Peptides

Additional peptide candidates under evaluation. Timeline dependent on FDA regulatory developments and emerging clinical data.

Timeline is subject to change based on FDA regulatory decisions. All peptide therapies are compounded by a US-based, state-licensed 503A pharmacy under individual patient prescription following physician evaluation. Compounded medications are not FDA-approved for safety or efficacy. Individual results vary. This content is educational and does not constitute medical advice.

Pending FDA 503A Pathway

Join the Peptide Roadmap Waitlist

Be the first to know when peptide therapies become available through Bloom Metabolics. We will notify you as each tranche clears the regulatory pathway.

Join the Waitlist